COVID-19, SARS-CoV-2, and Export Controls

被引:1
|
作者
Millett, Piers [1 ,2 ]
Rutten, Paul [3 ]
机构
[1] iGEM Fdn, Safety & Secur, 27 Drydock Ave,Suite 27E-230, Boston, MA 02210 USA
[2] Univ Oxford, Future Humanity Inst, Oxford, England
[3] Univ Oxford, Dept Plant Sci, Oxford, England
基金
英国生物技术与生命科学研究理事会;
关键词
COVID-19; SARS; Dual-use science; International coordination; Export controls; TOOLS; VISTA;
D O I
10.1089/hs.2020.0048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Export controls are intended to prevent the proliferation of materials that could be misused to make biological weapons. They are not intended to stifle critical research and development in the midst of a pandemic. This article explores how and why export controls might apply to severe acute respiratory syndrome coronavirus 2, the virus that causes coronavirus disease 2019. It outlines the taxonomic and genetic factors associated with the current approach to export control lists and discusses how they lead to unnecessary ambiguity. The authors describe ways in which the current export control systems might be revised in the short, medium, and long term, including sequence, disease, and function-based approaches.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 50 条
  • [21] SARS-CoV-2: The Monster Causes COVID-19
    Song, Chang
    Li, Zesong
    Li, Chen
    Huang, Meiying
    Liu, Jianhong
    Fang, Qiuping
    Cao, Zitong
    Zhang, Lin
    Gao, Pengbo
    Nie, Wendi
    Luo, Xueyao
    Kang, Jianhao
    Xie, Shimin
    Lyu, Jianxin
    Zhu, Xiao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [22] Overview of SARS-CoV-2 and COVID-19 Vaccine
    Alhaibil, Nada Abdullah
    BAHRAIN MEDICAL BULLETIN, 2021, 43 (02) : 511 - 515
  • [23] Pandemie durch SARS-CoV-2/Covid-19
    Matthias Schrappe
    Hedwig François-Kettner
    Franz Knieps
    Holger Pfaff
    K. Püschel
    Gerd Glaeske
    Medizinrecht, 2020, 38 (8) : 637 - 644
  • [24] SARS-CoV-2 seroprevalence in COVID-19 hotspots
    Eckerle, Isabella
    Meyer, Benjamin
    LANCET, 2020, 396 (10250): : 514 - 515
  • [25] Computation to Fight SARS-CoV-2 (COVID-19)
    Brogi, Simone
    Calderone, Vincenzo
    COMPUTATION, 2023, 11 (09)
  • [26] Decoding Covid-19 with the SARS-CoV-2 Genome
    Phoebe Ellis
    Ferenc Somogyvári
    Dezső P. Virok
    Michela Noseda
    Gary R. McLean
    Current Genetic Medicine Reports, 2021, 9 : 1 - 12
  • [27] SARS-CoV-2/COVID-19: a primer for cardiologists
    A. A. F. de Vries
    Netherlands Heart Journal, 2020, 28 : 366 - 383
  • [28] In Focus: SARS-CoV-2 and the COVID-19 Pandemic
    Giunta, Riccardo E.
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2020, 52 (03) : 220 - 220
  • [29] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [30] SARS-CoV-2 Targets and COVID-19 Vaccines
    Currier, Arthur W.
    Jeshurin, Madeline C.
    Sampson, Valerie B.
    COVID, 2021, 1 (03): : 608 - 621